Cancer Research and Treatment10.4143/crt.2014.1062015474796-803Can Serum be Used for Analyzing the <i>KRAS</i> Mutation Status in Patients with Advanced Colorectal Cancer?Seung Tae Kim, Won Jin Chang, Lihua Jin, Jae Sook Sung, Yun Ji Choi, Yeul Hong Kim,,
European Journal of Cancer10.1016/s0959-8049(11)72448-0201147S6349136 POSTER Can Serum Be Used for Analyzing the EGFR Mutation Status in Patients With Advanced Non-Small Cell Cancer (NSCLC)?S. Kim, H. Jung, J. Sung, U. Jo, Y. Kim, S. Shin, T. Tanaka, K. Hagiwara, Y. Choi,
Clinical Colorectal Cancer10.1016/j.clcc.2011.10.005201211285-87To Give or Not to Give Anti–Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies to Patients With KRAS G13D Mutation in Advanced Colorectal CancerRichard Kim, Timothy Kubal,
10.21203/ F-FDG uptake heterogeneity predicts KRAS/NRAS/BRAF mutation status in patients with liver metastases of colorectal cancerGuang Ma, Fangsong Zhang, Qiufang Liu, Lingling Pan, Jianping Zhang, Yingjian Zhang, Shaoli Song,
10.21203/ characteristics of MMR protein, KRAS-NRAS-BRAF gene mutation, HER-2 and PD-L1 status in 3822 Chinese colorectal cancer patientsLi Zhang, Nan Chen, Zhongwu Li, Aiwen Wu, Jie Chen,
International Journal of Colorectal Disease10.1007/s00384-012-1525-42012285733-734Letter to the Editor: Worse prognosis caused by anti-EGFR treatment in advanced colorectal cancer patients with KRAS mutationPeihao Yin, Yanyan Qiu, Qi Li,,
Clinical Colorectal Cancer10.1016/j.clcc.2019.05.0042019184e309-e315KRAS Status as a Predictor of Chemotherapy Activity in Patients With Metastatic Colorectal CancerNirit Yarom, Gillian Gresham, Nana Boame, Derek Jonker,
Clinical Colorectal Cancer10.3816/ccc.2010.n.00320109122-30KRAS Mutation Screening in Colorectal Cancer: From Paper to PracticeMarwan M. Fakih,
Cancer10.1002/cncr.300852016122172698-2707Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastasesGeorgios A. Margonis, Yuhree Kim, Kazunari Sasaki, Mario Samaha, Neda Amini, Timothy M. Pawlik,
Scientific Reports10.1038/s41598-019-53039-y201991Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patientsZhouhuan Dong, Linghong Kong, Zhiyi Wan, Fengwei Zhu, Mei Zhong, Yali Lv, Po Zhao, Huaiyin Shi,,